These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 20672530)
1. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy. Malesker MA; Hilleman DE Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530 [TBL] [Abstract][Full Text] [Related]
2. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy. Baser O; Andrews LM; Wang L; Xie L J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914 [TBL] [Abstract][Full Text] [Related]
3. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [TBL] [Abstract][Full Text] [Related]
4. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
6. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE; Scott LJ Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840 [TBL] [Abstract][Full Text] [Related]
7. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study. Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR; Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192 [TBL] [Abstract][Full Text] [Related]
8. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study. Saito I; Saruta T; Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866 [TBL] [Abstract][Full Text] [Related]
9. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
10. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455 [TBL] [Abstract][Full Text] [Related]
11. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine. Ferri C; Croce G; Desideri G Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492 [TBL] [Abstract][Full Text] [Related]
12. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension. Deeks ED Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis: controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) study. Saito I; Fujikawa K; Saruta T; Hypertens Res; 2008 Jul; 31(7):1399-405. PubMed ID: 18957811 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy]. Ke YN; Huang J; Zhu JR; Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):794-9. PubMed ID: 20128376 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination. Kostis JB Am J Ther; 2010; 17(2):188-96. PubMed ID: 19433970 [TBL] [Abstract][Full Text] [Related]
17. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy. Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097 [TBL] [Abstract][Full Text] [Related]
18. Initial combination therapy with amlodipine/valsartan compared with monotherapy in the treatment of hypertension. Philipp T; Glazer RD; Wernsing M; Yen J J Am Soc Hypertens; 2011; 5(5):417-24. PubMed ID: 21592879 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population. Franco RJ; Goldflus S; McQuitty M; Oigman W; Blood Press Suppl; 2003 Dec; 2():41-7. PubMed ID: 14761076 [TBL] [Abstract][Full Text] [Related]
20. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)]. Chazova IE; Martynyuk TV Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]